Pharma

Your Article Summary

See Latest Articles

Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US
Novartis, 04/09/09

Coartem, the leading artemisinin-based combination treatment for malaria worldwide, has been approved by the US Food and Drug Administration. Coartem is a fixed-dose combination of two novel antimalarials. It is a highly-effective three-day malaria treatment with cure rates of over 96% even in areas of multi-drug resistance.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals